BIMI International Medica... (BIMI)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Company Description

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China.

The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies.

It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China.

The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines.

In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name.

Further, the company provides medical services in the hospitals, as well as IT research and development services.

It sells its medicine and other healthcare products to customers through its directly owned stores.

The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021.

BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.

BIMI International Medical Inc.
BIMI International Medical Inc. logo
Country CN
IPO Date Oct 18, 2006
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 296
CEO Tiewei Song

Contact Details

Address:
Chongqing Corporation Avenue
Chongqing,
CN
Website https://www.usbimi.com/index.html

Stock Details

Ticker Symbol BIMI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001213660
CUSIP Number 099501108
ISIN Number US05552Q3011
Employer ID 02-0563302
SIC Code 5122

Key Executives

Name Position
Tiewei Song Chief Executive Officer & Director
Baiqun Zhong Interim Chief Financial Officer
Xiaoping Wang Chief Operating Officer
Fnu Oudom Chairman of Board & President

Latest SEC Filings

Date Type Title
Jul 29, 2024 8-K Current Report
Jun 20, 2024 SCHEDULE 13D/A [Amend] Filing
Jun 17, 2024 SCHEDULE 13D Filing
Jun 13, 2024 4 Filing
Jun 04, 2024 8-K Current Report
May 24, 2024 8-K Current Report
May 20, 2024 8-K Current Report
Apr 23, 2024 8-K Current Report
Apr 02, 2024 NT 10-K Filing
Mar 28, 2024 8-K Current Report